Sign In
Buy OMCL
$41.89
-0.0200 (-0.0477%)
At Close: Jun 03, 2026
Medical Products Stock Earnings on Nov 2: IDXX, STE & More
12:15pm, Monday, 01'st Nov 2021
With the pandemic raging on, testing, vaccine and therapeutic makers are witnessing huge market adoption of their COVID-related support products in Q3.
CNVY vs. OMCL: Which Stock Should Value Investors Buy Now?
01:27pm, Thursday, 14'th Oct 2021
CNVY vs. OMCL: Which Stock Is the Better Value Option?
FDS Amplicare Hosts Webinar to Advise Pharmacists on Assisting Customers During Medicare Open Enrollment
10:12am, Wednesday, 06'th Oct 2021
FORT WORTH, Texas, Oct. 6, 2021 /PRNewswire/ -- FDS Amplicare, which builds industry-leading SaaS technology solutions that strengthen the health of retail pharmacies and their patients, today annou
3 Sectors Looking Up Ahead of Q3 Earnings Despite COVID-19 Woes
11:49am, Monday, 04'th Oct 2021
There has been notable job gains in automotive, hospitality, retail, social assistance and in professional and business services through the past few months.
3 Reasons Growth Investors Will Love Omnicell (OMCL)
01:54pm, Tuesday, 28'th Sep 2021
Omnicell (OMCL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
CPSI vs. OMCL: Which Stock Is the Better Value Option?
01:08pm, Tuesday, 28'th Sep 2021
CPSI vs. OMCL: Which Stock Is the Better Value Option?
Here's Why You Should Add Omnicell (OMCL) to Your Portfolio
12:16pm, Friday, 24'th Sep 2021
Investors continue to be optimistic about Omnicell (OMCL) on its strategic acquisitions and partnerships supporting each of the three legs of its strategy.
Omnicell (OMCL) New Buyout Expands Patient Engagement Suite
11:56am, Monday, 13'th Sep 2021
With the FDS Amplicare acquisition, Omnicell (OMCL) is expected to gain from several healthcare trends, banking on its offerings of digital technologies, SaaS solutions, and tech-enabled services.
Omnicell Completes Acquisition of FDS Amplicare
04:11pm, Thursday, 09'th Sep 2021
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Completes Acquisition of FDS Amplicare
Is Omnicell (OMCL) a Solid Growth Stock? 3 Reasons to Think " Yes "
02:10pm, Thursday, 09'th Sep 2021
Omnicell (OMCL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
3 MedTech Sectors Benefiting Despite COVID-19 Resurgence
12:30pm, Wednesday, 08'th Sep 2021
Here we discuss three major subsectors of MedTech and some of their constituent stocks for which COVID-19 has opened up enormous growth prospects.
Omnicell Grows International Footprint with Opening of Omnicell India Software Development Center
11:27pm, Monday, 06'th Sep 2021
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it ha
4 MedTechs to Gain in 2H21 Beating the Delta Variant-Led Dip
12:58pm, Tuesday, 31'st Aug 2021
Investors can choose to invest in MedTech stocks like VREX, OMCL, STAA, and IDXX that have shown tremendous promise amid the pandemic.
Omnicell (OMCL) Enhances Medication Management With New Release
12:20pm, Wednesday, 25'th Aug 2021
Omnicell's (OMCL) Summer 2021 Release offers greater platform deployment options, providing customers better flexibility and improving time to value for strategic initiatives.
Looking for a Growth Stock? 3 Reasons Why Omnicell (OMCL) is a Solid Choice
03:19pm, Monday, 23'rd Aug 2021
Omnicell (OMCL) possesses solid growth attributes, which could help it handily outperform the market.
